抗TATA盒結合蛋白(TBP)單克隆抗體
Anti-TATA Binding Protein (TBP) Monoclonal Antibody
GTF2D; GTF2D1; SCA17; TFIID; TATA sequence-binding protein; TATA-box factor; Transcription initiation factor TFIID TBP subunit
- 編號UFAB703Hu04
- 物種Homo sapiens (Human，人) 相同的名稱，不同的物種。
- 效價C3
- Ig亞型 IgG
- 純化方式抗原特異性親和純化
- 標記物無標記物
- 激發(fā)波長
- 單次使用量
- 緩沖液成份磷酸鹽緩沖液（pH7.4,含有0.02% NaN3和50%甘油）
- 性狀液體
- 且適物種-
- 應用FCM
- 下載 英文說明書 中文說明書
- 規(guī)格 25test50test 100test 200test 500test
- 價格 ¥ 360 ¥ 600 ¥ 960 ¥ 1200 ¥ 2100
- 欲了解實際交易價格和更多情況，請與當?shù)亟涗N商聯(lián)系!
-
產品包裝(模擬)
-
產品包裝(模擬)
-
Human Hela cell line was fixed with 2% paraformaldehyde (10 min) , permeabilised with 0.2% BSA-Triton X-100,then stained with 10μg/ml mouse Anti-human TBP Monoclonal Antibody (Catalog FAB703Hu04, red histogram) or Isotype control antibody (Catalog IS067-Mu02, green histogram), followed by 1μg/ml FITC-conjugated Anti-mouse IgG Secondary Antibody (Catalog SAA544Mu18).
-
通過ISO 9001、ISO 13485質量體系認證
用法
Flow cytometry: 10μg/ml;
Optimal working dilutions must be determined by end user.
儲存
經常使用則4°C保存。-20°C保存不超過一年。避免反復凍融。
贈品
增值服務
相關產品
| 編號 | 適用物種：Homo sapiens (Human，人) | 應用(僅供研究使用，不用于臨床診斷！) |
| URPB703Hu01 | TATA盒結合蛋白(TBP)重組蛋白 | Positive Control; Immunogen; SDS-PAGE; WB. |
| UMAB703Hu27 | TATA盒結合蛋白(TBP)單克隆抗體 | WB; IHC; ICC; IP. |
| UMAB703Hu29 | TATA盒結合蛋白(TBP)單克隆抗體 | WB; IHC; ICC; IP. |
| UMAB703Hu22 | TATA盒結合蛋白(TBP)單克隆抗體 | WB |
| UMAB703Hu23 | TATA盒結合蛋白(TBP)單克隆抗體 | WB |
| UMAB703Hu24 | TATA盒結合蛋白(TBP)單克隆抗體 | WB; ICC/IF |
| UMAB703Hu25 | TATA盒結合蛋白(TBP)單克隆抗體 | WB |
| UMAB703Hu21 | TATA盒結合蛋白(TBP)單克隆抗體 | WB |
| UMAB703Hu26 | TATA盒結合蛋白(TBP)單克隆抗體 | WB |
| UMAB703Hu28 | TATA盒結合蛋白(TBP)單克隆抗體 | WB |
| UFAB703Hu02 | 抗TATA盒結合蛋白(TBP)單克隆抗體 | FCM |
| UFAB703Hu04 | 抗TATA盒結合蛋白(TBP)單克隆抗體 | FCM |
參考文獻
| 雜志 | 參考文獻 |
| Mol Med Rep | Ginsenoside Re exhibits neuroprotective effects by inhibiting neuroinflammation via CAMK/MAPK/NF?κB signaling in microglia [34368872] |
| Mol Biol Rep | Genomic organization and hypoxia inducible factor responsive regulation of teleost hsp90β gene during hypoxia stress [34460062] |
留言咨詢
